Mirum Pharmaceuticals, Inc. MIRM Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s interest income?
- Mirum Pharmaceuticals, Inc. (MIRM) reported interest income of $3.4M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s interest income increased by 12.5% year-over-year, from $3.02M to $3.4M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s interest income has grown at a 142.8% compound annual growth rate (CAGR), from $366K to $12.73M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.